Dr. Manja Bouman has been Chief Executive Officer of Kiadis Pharma since 2004. Prior to joining Kiadis Pharma, Dr. Manja Bouman was Vice President Licensing and Technology at DSM pharmaceutical products. Dr. Manja Bouman worked for 10 years at DSM in different business development and business management positions. Dr. Manja Bouman holds a PhD in Biochemistry from the University of New York, USA.

Robbert van Heekeren is Chief Financial Officer. Before joining Kiadis Pharma he was Executive Director, Head Global Finance & Control at Organon. He worked for Organon for more than 10 years in international management positions. Robbert van Heekeren holds a Masters degree in Economics from Tilburg University, The Netherlands and a Masters degree in Industrial Engineering & Management Science from Eindhoven University of Technology, The Netherlands.

Dr. Maarten Egeler is a pediatric stem cell transplantation physician and an internationally recognized authority in pediatric hemato-oncology. Next to his position at Kiadis Pharma Dr. Maarten Egeler is also Head of the division of Pediatric Hemato-Oncology at the University of Leiden. Dr. Maarten Egeler brings 25 years of experience in the medical field of hematology, oncology and stem cell transplantation. Dr. Maarten Egeler obtained his medical degree at the University of Leiden, The Netherlands and his PhD at the University of Amsterdam, The Netherlands.
 

Dr. Edwin Wagena is Vice President Clinical Development. Prior to joining Kiadis Pharma Dr. Edwin Wagena worked for over 10 years in designing, conducting and managing clinical trials and clinical development programs for Solvay Pharmaceuticals and Astellas Pharma. Dr. Edwin Wagena obtained his PhD at Maastricht University, The Netherlands focussing on clinical epidemiological research. 

Rob Dekker is Vice President Technical Operations. Before joining Kiadis Pharma, Rob Dekker worked in GMP operations management at Octoplus and Biogen Idec after obtaining his manufacturing and process development experience at DSM Biologics. Rob Dekker has over 15 years of experience in biotech operations and holds a Masters degree in Medical Biology from the Vrije Universiteit Amsterdam, The Netherlands.

Charmaine Augustinus is Vice President Regulatory Affairs and Quality Affairs. Prior to joining Kiadis Pharma, Charmaine Augustinus served as Director Regulatory Affairs and Clinical Strategy at Shire Pharmaceuticals. She has 25 years of Regulatory Affairs experience with Shire, UCB Celltech, Solvay Pharmaceuticals and Schering AG. Charmaine Augustinus is a pharmacist and holds an MBA degree from IMC Buckingham, UK.

Margot Hoppe is General Counsel & Corporate Secretary. She has over 20 years of experience in corporate legal affairs and worked for various biotechnology companies including Gist-Brocades and DSM. Margot Hoppe has a Masters degree in Law and Political Science from the Erasmus University of Rotterdam, The Netherlands.